Baird lowered the firm’s price target on Contineum (CTNM) to $16 from $32 and keeps an Outperform rating on the shares. The firm said its Phase 2 results in relapsing-remitting MS is on track ...

“2025 is shaping up to be a pivotal year, as we have several important clinical data readouts and trial initiations on the horizon,” said Carmine Stengone, CEO, Contineum (CTNM) Therapeutics.

CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications ...

These 12 undervalued financial-services stocks look attractive today. Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a ...

SAN DIEGO--(BUSINESS WIRE)-- Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the ...

1 Day CTNM -1.40% DJIA 1.39% Russell 2K 1.09% Health Care/Life Sciences -0.37% ...

A road bike is essential for any triathlete. Even if you have a dedicated triathlon bike, you’ll still want a road bike for training, but you can also use it for racing. In fact, it may even be ...

Event has submitted the required documentation for a permit, this has been reviewed and a permit has been issued by British Triathlon. This is an indoor event. Both run and cycle elements will be ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...